Cargando…

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities

Detalles Bibliográficos
Autores principales:	Crowley, JJ, Mekkes, JR, Zouboulis, CC, Scheinfeld, N, Kimball, A, Sundaram, M, Gu, Y, Okun, MM, Kerdel, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298243/ https://www.ncbi.nlm.nih.gov/pubmed/24842009 http://dx.doi.org/10.1111/bjd.13122

Ejemplares similares

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled portion of a phase 2 adalimumab study
por: Kimball, A.B., et al.
Publicado: (2015)

Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
por: Tzellos, Thrasyvoulos, et al.
Publicado: (2020)

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
por: Kimball, Alexandra B., et al.
Publicado: (2018)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
por: Zouboulis, Viktor A., et al.
Publicado: (2021)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021)

Atypical Hidradenitis Suppurativa on the Leg in a Psoriatic Patient
por: Yasuda, Masahito, et al.
Publicado: (2020)

Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy
por: Ring, Hans Christian, et al.
Publicado: (2022)

Clinical Epidemiology and Management of Hidradenitis Suppurativa
por: Sayed, Christopher J., et al.
Publicado: (2021)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities
por: Lim, Ziying Vanessa, et al.
Publicado: (2016)

Comorbidities of hidradenitis suppurativa: A review of the literature
por: Cartron, Alexander, et al.
Publicado: (2019)

Quality of Life in Hidradenitis Suppurativa: An Update
por: Chernyshov, Pavel V., et al.
Publicado: (2021)

Management of mild hidradenitis suppurativa: our greatest challenge yet
por: van der Zee, H.H., et al.
Publicado: (2021)

Cryosurgery-Induced Pneumomediastinum in a Young Woman with Hidradenitis Suppurativa
por: Gomes, Nuno Miguel Preto, et al.
Publicado: (2022)

An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis
por: Tricarico, Paola M., et al.
Publicado: (2019)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

New treatments and new assessment instruments for Hidradenitis suppurativa
por: van Straalen, Kelsey R., et al.
Publicado: (2022)

High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa
por: van Straalen, K.R., et al.
Publicado: (2020)

Effect of Hidradenitis Suppurativa Disease Duration on Psychiatric Comorbidity
por: TIRI, Hannu, et al.
Publicado: (2020)

Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice
por: Kimball, A.B., et al.
Publicado: (2020)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Bertolotti, A., et al.
Publicado: (2021)

A severe case of hidradenitis suppurativa
por: Cubas, Vanessa, et al.
Publicado: (2016)

Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
por: Prens, Errol P., et al.
Publicado: (2020)

Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)

Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population
por: Kirsten, Natalia, et al.
Publicado: (2020)

Metabolic and Endocrine Comorbidities in Hidradenitis Suppurativa: A Nationwide Study
por: Edigin, Ehizogie, et al.
Publicado: (2021)

Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa
por: Hua, Vivian J., et al.
Publicado: (2021)

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2020)

New Data on the Features of Skin Barrier in Hidradenitis Suppurativa
por: Somogyi, Orsolya, et al.
Publicado: (2023)

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials
por: Jemec, G.B.E., et al.
Publicado: (2019)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality
por: Ingram, J.R., et al.
Publicado: (2016)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches
por: Ardon, C.B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2044cgeajl0t4kk8tv624pef3n